Greater Trochanteric Pain Syndrome of Both Lower LimbsNCT04707274
Reliability, Validity, and Cross-cultural Adaptation of the Turkish Version of the Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire
An observational study of Greater Trochanteric Pain Syndrome of Both Lower Limbs and Gluteal Tendinitis, run by Gazi University at 1 site in Turkey (Türkiye).
Trial summary
The purpose of this study was to investigate adaptation, validity, and reliability of the Turkish version of the Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Greater Trochanteric Pain Syndrome of Both Lower Limbs, Gluteal Tendinitis
- What is being tested?
- Survey study
- How many people
- 108 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jan 2022to 1 Jul 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population will consist of individuals with diagnosis of greater trochanteric pain syndrome and gluteal tendinopathy.
Who may be able to join
- Trochanteric bursitis and/or gluteal tendinopathy,
- Lateral hip pain,
- Pain on palpation of the greater trochanter,
- History of pain when lying on the ipsilateral side or during weight-bearing activities, aggravated by activity for more than 3 months.
Who cannot join
- Hip osteoarthritis,
- Systemic inflammatory disease such as rheumatoid arthritis,
- Lumbar spine nerve root findings,
- History of lumbar spine or ipsilateral hip joint surgery,
- Osteogenic disease such as Paget's disease,
- Corticosteroid injection to the ipsilateral hip in the past 3 months,
- Hip surgery.
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study was to investigate adaptation, validity, and reliability of the Turkish version of the Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire.
Read the detailed description
Gluteal tendinopathy, also known as greater trochanteric pain syndrome, interferes with physical function and sleep, and is characterized by pain and tenderness over the greater trochanter.Clinical risk factors for the development of this condition include advanced age, female gender, back pain, overweight / obesity, poor abductor hip function, altered gait parameters, and psychological distress. The Victorian Institute of Sports Assessment for Gluteal tendinopathy (VISA-G) Questionnaire has recently designed as a patient-reported condition-specific outcome measurement tool to assess disability due to tendinopathy. VISA-G is scored between 0 and 100 (a higher score is expected) and consists of eight items covering three main areas (pain, function, and current activity level). Visual analog score for pain (0-10), the effect of pain on weight-bearing activities (0-30), and difficulty and / or function-related stairs use, including lying on the symptomatic side (0-10), climbing ramps (0-10), standing up without sitting (0-10), home or garden work (0-10) and regular exercise (0-10), physical activity and sports participation (0-10) are evaluated. The study is planned with 40 individuals with gluteal tendinopathy. After questioning the sociodemographic characteristics of the individuals, the patients will be asked to fill in VISA-G, Short Form-36, International Physical Activity Questionnaire, Numeric Rating Scale, Oswestry Disability Index, Oxford Hip Score and modified Harris Hip Score.Test-retest will be re-applied to those of the same individuals who can be reached after 1 week. The results will be analyzed using the SPSS version 22.0 computer package program.
- Being tested
- Survey study
- Keywords
- Validity, Reliability, Greater Trochanteric Pain Syndrome, Gluteal tendinopathy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Survey studyOther
Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire will be applied.
| Study group | Role | What they receive |
|---|---|---|
| Patients group | Individuals with greater trochanteric pain syndrome and gluteal tendinopathy Receives: Other: Survey study |
What is being measured
The primary outcome is the main question the study is designed to answer.
Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire
Victorian Institute of Sports Assessment for Gluteal Tendinopathy Questionnaire is designed to assess disability due to gluteal tendinopathy.
Measured: 10 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jan 2021
- Study start1 Jan 2022
- Primary completion1 Jun 2022
- Study completion1 Jul 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Greater Trochanteric Pain Syndrome of Both Lower LimbsStudies of the same condition, open and under way.
- More trials run by Gazi UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 108 participants (actual)
Sponsor and investigators
- Lead sponsor
- Gazi University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Halime ARIKAN, Gazi University
- Investigators
- Seyit CITAKER, Dr., Principal investigator, Gazi University, Faculty of Health SciencesM. Baybars ATAOGLU, Dr., Principal investigator, Gazi University, Faculty of MedicineGokhan MARAS, MSc., Principal investigator, Gazi University, Faculty of Health SciencesHalime ARIKAN, MSc., Principal investigator, Ankara University, Faculty of Health SciencesI. Hazal AYAS, MSc., Principal investigator, Gazi University, Faculty of Health SciencesBeyza YAZGAN DAGLI, MSc., Principal investigator, Gazi University, Faculty of Health Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04707274
- Sponsor's protocol ID
- E.137836
- Status last verified
- Jan 2022
- First submitted
- 10 Jan 2021
- Last updated
- 8 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 8 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Reliability, Validity, and Cross-cultural Adaptation of the Turkish Version of the Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire
- ClinicalTrials.gov ID
- NCT04707274
- Acronym / sponsor ID
- E.137836
- Keywords
- Validity, Reliability, Greater Trochanteric Pain Syndrome, Gluteal tendinopathy
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 108 participants (actual)
- Lead sponsor
- Gazi UniversityUniversity, hospital or other
- Study start
- 1 Jan 2022 (actual)
- Primary completion
- 1 Jun 2022 (actual)
- Study completion
- 1 Jul 2022 (actual)
- First posted
- 13 Jan 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study was to investigate adaptation, validity, and reliability of the Turkish version of the Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire.
Detailed description
Gluteal tendinopathy, also known as greater trochanteric pain syndrome, interferes with physical function and sleep, and is characterized by pain and tenderness over the greater trochanter.Clinical risk factors for the development of this condition include advanced age, female gender, back pain, overweight / obesity, poor abductor hip function, altered gait parameters, and psychological distress. The Victorian Institute of Sports Assessment for Gluteal tendinopathy (VISA-G) Questionnaire has recently designed as a patient-reported condition-specific outcome measurement tool to assess disability due to tendinopathy. VISA-G is scored between 0 and 100 (a higher score is expected) and consists of eight items covering three main areas (pain, function, and current activity level). Visual analog score for pain (0-10), the effect of pain on weight-bearing activities (0-30), and difficulty and / or function-related stairs use, including lying on the symptomatic side (0-10), climbing ramps (0-10), standing up without sitting (0-10), home or garden work (0-10) and regular exercise (0-10), physical activity and sports participation (0-10) are evaluated. The study is planned with 40 individuals with gluteal tendinopathy. After questioning the sociodemographic characteristics of the individuals, the patients will be asked to fill in VISA-G, Short Form-36, International Physical Activity Questionnaire, Numeric Rating Scale, Oswestry Disability Index, Oxford Hip Score and modified Harris Hip Score.Test-retest will be re-applied to those of the same individuals who can be reached after 1 week. The results will be analyzed using the SPSS version 22.0 computer package program.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients group | – | Other: Survey studyIndividuals with greater trochanteric pain syndrome and gluteal tendinopathy |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population will consist of individuals with diagnosis of greater trochanteric pain syndrome and gluteal tendinopathy.
Key inclusion criteria (4 listed)
- Trochanteric bursitis and/or gluteal tendinopathy,
- Lateral hip pain,
- Pain on palpation of the greater trochanter,
- History of pain when lying on the ipsilateral side or during weight-bearing activities, aggravated by activity for more than 3 months.
Key exclusion criteria (7 listed)
- Hip osteoarthritis,
- Systemic inflammatory disease such as rheumatoid arthritis,
- Lumbar spine nerve root findings,
- History of lumbar spine or ipsilateral hip joint surgery,
- Osteogenic disease such as Paget's disease,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Survey studyVictorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire will be applied. | Other | Patients group |
Primary outcome
Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire
Time frame: 10 minutes
Victorian Institute of Sports Assessment for Gluteal Tendinopathy Questionnaire is designed to assess disability due to gluteal tendinopathy.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Apr 2025.
- Individual participant dataSharing planned: Yes
Related trials for Greater Trochanteric Pain Syndrome of Both Lower Limbs
Recruiting
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain
Greater Trochanteric Pain Syndrome, Greater Trochanteric Pain Syndrome of Both Lower Limbs
Active, not recruiting
Shock Wave Therapy Plus Exercise in GTPS
Greater Trochanteric Pain Syndrome of Both Lower Limbs
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Seyit CITAKER, Dr. principal investigator
Gazi University, Faculty of Health Sciences
M. Baybars ATAOGLU, Dr. principal investigator
Gazi University, Faculty of Medicine
Gokhan MARAS, MSc. principal investigator
Gazi University, Faculty of Health Sciences
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Greater Trochanteric Pain Syndrome of Both Lower Limbs and Gluteal Tendinitis, run by Gazi University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire (time frame: 10 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2025.